exhibited higher levels of the DNA damage marker γH2AX (3.9-fold, p < 0.01, vs. control SMC). These features did not correlate with patients' chronological age and are therefore potential markers for pathological premature vascular aging. Early-stage PCA-SMC (control and aneurysmal) were indistinguishable from one another across all parameters. The principal limitation of human studies is tissue availability only at the end stage of the disease. Refinement of a porcine bioreactor model would facilitate the study of temporal modulation of SMC behaviour during aneurysm development and potentially identify therapeutic targets to limit AAA progression.
associated with a high mortality risk of 60-70%; consequently, national screening programmes have been established to detect AAA in men over the age of 65 years [1] . Elective open or endovascular repair is then offered when the risks of intervention are outweighed by the annual risk of rupture, which is correlated with AAA size.
AAA is a multi-factorial disease. The pro-inflammatory infiltration of the aorta by immune cells such as macrophages and lymphocytes has been recognised for many years and it has consequently been the focus of intensive research [2] . In addition to the inflammatory component, AAA is characterised by a progressive decline in the number of smooth muscle cells (SMC) within the aortic wall [3] and degradation of extracellular matrix through the production of matrix metalloproteinases (MMP) [4] . In combination, this weakens the structural integrity of the aorta, rendering it more susceptible to rupture.
SMC are the principal cellular component of the vascular wall and they play essential roles in maintaining vessel architecture and remodelling in response to environmental stimuli. They do this through switching between contractile (differentiated) and synthetic (dedifferentiated) phenotypes [5] . Whilst this plasticity is essential to adaptive remodelling, it is also implicated in the development of human AAA [6] [7] [8] [9] and animal models of abdominal and thoracic aneurysm [6, 10] . Undeniably the involvement of SMC in AAA progression is an area worthy of research; however, the key challenge facing investigators is that human tissue is accessible only at the end stage of the disease. Whilst animal models are undoubtedly of great value in AAA research, they do not fully recapitulate the clinical scenario in humans as they are most commonly artificially induced via treatment with angiotensin II, calcium chloride, or elastase or mechanically induced using balloon angioplasty [11] . As such, they benefit from being complemented with alternative models.
SMC isolated from end-stage human tissue exhibit diverse features in culture [7] [8] [9] . Recently, we described a distinct SMC phenotype isolated from end-stage human AAA tissue (aortic diameter ≥ 5 cm) characterised by a large rhomboid morphology, a slow proliferative rate, increased senescence, and reduced levels of secreted MMP-2 compared to SMC cultured from non-aneurysmal human saphenous vein (SV) [9] . Furthermore, we established a novel ex vivo bioreactor model whereby porcine carotid arteries (PCA) were briefly treated with a combination of collagenase and elastase (CCE) or control vehicle gel (VEH) and then maintained under flow for 12 days in a bioreactor. During this time, dilatation of the vessel was apparent and importantly CCE-SMC derived from the vessels retrieved at the end of the culture period were compatible with those of end-stage human AAA-SMC with respect to morphology and behaviour in culture [9] . There is clearly a demand for models that may help identify factors that precede aneurysm development in order to find targets for new therapeutics.
The risk of AAA increases with age [1] ; however, the effects of aging on SMC are controversial, with multiple conflicting reports regarding its influence on SMC proliferation, migration, and inflammation [recently reviewed in 12 ] . Some of the phenotypic features of AAA-SMC that we have described, i.e., an aberrant morphology, increased senescence, and a poor proliferative capacity [9] , correspond to features apparent in aged SMC [13] ; however, our observation of reduced MMP-2 secretion is at variance with animal models of aging [14] . Aging is associated with an increased production of proinflammatory cytokines [15] and the development of cellular senescence, which has a multitude of effects on cell phenotype and behaviour [16] . We hypothesised that human AAA-SMC and porcine CCE-SMC would display features consistent with a premature aging phenotype. Consequently, the purpose of this study was to perform a detailed sideby-side comparison of human AAA-SMC and porcine CCE-SMC. Cells were explored in terms of morphology, expression of markers associated with aging and senescence (sirtuin-1, sirtuin-3, sirtuin-6, and miR-145), and evaluation of DNA damage (γH2AX). In a further series of experiments, we also examined these features in porcine cells cultured from vessels maintained in the bioreactor for a shorter interval (3 days) to explore the temporal nature of aneurysm pathology.
Methods

Human Cell Isolation
Human SMC were isolated using an explantation technique as previously described [17] . Aneurysmal (AAA) SMC were isolated from tissue fragments from patients undergoing open surgical repair, and non-aneurysmal SMC were isolated from SV or internal mammary artery (IMA) of patients undergoing coronary artery bypass grafting. The mean aneurysm diameter was 6.48 ± 0.22 cm (range 4.9-9.5). All procedures were performed at the Leeds General Infirmary. Approval of the experimental protocol was given by the Leeds West Research Ethics Committee (reference CA/01/040) and all patients gave informed, written consent. This study conformed to the Declaration of Helsinki. Following explantation, established SMC were maintained in Dulbecco's modified Eagle medium supplemented with 10% foetal calf serum, 1% L-glutamine and 1% penicillin/ streptomycin fungizone (full growth medium; FGM) at 37 ° C in 5% CO 2 in air and serially passaged using trypsin/EDTA as necessary. All experiments were performed on cells between passages 3 and 6. 
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Bioreactor and Porcine Cell Isolation PCA were harvested from 4-month-old, 65-kg animals as previously described [9] . All procedures were performed according to UK Home Office regulations. Isolated vessels were treated with control gel (VEH) or gel containing CCE to induce an aneurysmlike dilatation of the vessel and maintained in a bioreactor under flow for 12 days (classified as "end stage"), as previously described [9] or 3 days (classified as "early stage"). SMC were subsequently explanted from the retrieved vessels and maintained in FGM. As for human SMC, experiments were performed on early passage cells (passages 3-6).
Light Microscopy
Sub-confluent cells in FGM were imaged under phase at ×100 magnification to examine any visible cytoskeletal and ultra-structural features. For quantification of multi-nucleation, multiple fields of view were acquired and the number of nuclei in ∼ 150 individual cells was determined. Multi-nucleated cells were represented as a proportion of the total number of cells examined.
Immunocytochemistry
Cells were cultured on glass coverslips in FGM for 96 h prior to fixation in 4% paraformaldehyde. The F-actin cytoskeleton was visualised using rhodamine phalloidin as previously described [18] . Both low-(×200) and high-magnification (×630) images were taken in multiple fields using an LSM510 Upright confocal microscope.
To examine nuclear morphology, 5 random fields of view were imaged for each DAPI-stained cell population at ×400 magnification. Nuclei were classified as "normal" (ovoid) or "aberrant" (irregular with blebbing, or apoptotic), and the proportion of aberrant nuclei was calculated. To aid the distinction between the 2 classifications, DAPI was visualised in yellow to give a clear contrast.
For quantification of γH2AX-positive nuclei, cells were stained with primary γH2AX antibody (1: 100) overnight followed by Cy3-conjugated donkey anti-rabbit secondary antibody (1: 400) for 3 h at room temperature before mounting using ProLong Gold containing DAPI nuclear stain. Five random fields of view were captured from each cell population at ×200 magnification. Data were expressed as the proportion of γH2AX-positive nuclei (pink) relative to the total number of nuclei (blue and pink).
RNA Isolation and RT-PCR
RNA was isolated from cells cultured in FGM and reverse transcribed as previously described [19] . Expression of SIRT-1, SIRT-3, and SIRT-6 in human and porcine cells was determined using specific TaqMan assays and expressed as a percentage of GAPDH.
For miR-145, RNA was reverse transcribed as previously described [20] and the expression of human and porcine miR-145 was determined using specific TaqMan assays and expressed as a percentage of short ribonuclear RNA, U6.
Statistical Analyses
Data are expressed as means ± SEM, with n representing the number of experiments on cells from different patients or animals. Statistical analysis was performed using GraphPad Prism and ratio t tests and 1-way ANOVA with the Newman-Keuls post hoc test as appropriate. Correlative data was tested for normality using the D'Agostino and Pearson omnibus test and any associations were identified using Spearman's or Pearson's correlation as appropriate. Correlation between different factors is indicated by r. p < 0.05 was considered statistically significant.
Results
SMC Morphology
AAA-SMC frequently presented perinuclear granulation, a feature seldom observed in non-aneurysmal SV or IMA-SMC ( Fig. 1 a) . Most strikingly, AAA-SMC often exhibited a defined, fragmented cytoskeleton that was clearly visible under light microscopy ( Fig. 1 a) . We examined the cytoskeleton in more detail using rhodamine phalloidin to stain F-actin fibres. Low-magnification images (×200) were used to illustrate that staining was apparent in all cells within the population, and high-magnification images (×630) were obtained to visualise the organisation of F-actin fibres in greater detail. Substantial fragmentation was evident under both low-and high-power magnification in AAA-SMC, in contrast to long, parallel Factin fibres that were visible in SV-SMC ( Fig. 1 b) and in IMA-SMC [21] .
As previously noted, porcine SMC were smaller than human SMC [9] , making perinuclear granulation and the cytoskeleton more difficult to decipher using light microscopy, although they were visible to a degree. There was no apparent difference in granulation or cytoskeletal prominence in any early-stage CCE-SMC ( Fig. 1 c) , and F-actin fibres were maintained in an ordered configuration resembling those of VEH-SMC ( Fig. 1 d) . In contrast, there was clear evidence of perinuclear granulation in end-stage CCE-SMC and disruption to the cytoskeleton which was not evident in VEH-SMC ( Fig. 1 e) , an observation that was exemplified using immunofluorescence ( Fig. 1 f) .
Senescence Markers
AAA-SMC expressed SIRT-1, SIRT-3, and SIRT-6 and had a significantly lower expression of SIRT-1 compared to SV-SMC but not IMA-SMC ( Fig. 2 a) . SIRT-3 and SIRT-6 were not different between the groups. SIRT-6 expression levels were consistently lower than those of SIRT-1 and SIRT-3 regardless of the SMC source ( Fig. 2 a) .
The reduced expression of SIRT-1 in AAA-SMC was not replicated in porcine SMC. In early-stage CCE-SMC, SIRT-1 expression was comparable to VEH-SMC in 2 of the 3 vessels studied; however, the third vessel had a higher expression of SIRT-1 in the VEH-SMC. This skewed the data, yet it remains non-significant ( p = 0.494; Fig. 2 c) . SIRT-3 was also unaffected by CCE treatment ( Fig. 2 c) .
In end-stage experiments, there were no significant differences between CCE-SMC and VEH-SMC ( Fig. 2 d) .
The expression of SIRT-1 and SIRT-3 was routinely higher in porcine SMC (by 2.6-and 2.1-fold, respectively) than in human cells, although the expression of SIRT-6 was undetectable in all porcine RNA samples (data not shown). Expression levels of miR-145 in AAA-SMC were >2-fold higher than in non-aneurysmal cells (57.4 vs. 26.0% in SV-SMC and 20.5% in IMA-SMC; Fig. 2 b) . However, we did not see this variance in porcine cells (neither early nor end stage) where overall expression levels were similar between all CCE-and VEH-SMC ( Fig. 2 e, f) .
Given that SV-and IMA-SMC were phenotypically comparable ( Fig. 1 , 2 ) we subsequently used SV-SMC as a non-aneurysmal comparator for the remainder of the study due to the ready availability of primary tissue and consistency with our published report [9] .
Markers of DNA Damage
AAA-SMC exhibited a higher frequency of multi-nucleation than SV-SMC, with 7.4% of cells containing 2 or more nuclei ( Fig. 3 a) . In contrast, only 1.8% of SV-SMC were multi-nucleated ( Fig. 3 a) . AAA-SMC also had a greater proportion of aberrant nuclei (18.5%), compared to 7.6% in SV-SMC ( Fig. 3 b) . Furthermore, 32.4% of AAA-SMC stained positively for γH2AX, compared to only 8.3% in SV-SMC ( Fig. 3 c) .
Early-stage SMC demonstrated a modest elevation in the proportion of multi-nucleated cells compared to endstage cells, either human or porcine. However, there was no difference between VEH-and CCE-SMC at this time point ( Fig. 3 d) . Consistent with this, there were few aberrant nuclei in either group ( Fig. 3 e) . In early-stage experiments, γH2AX-positive nuclei were frequent although the degree of DNA damage was minor, as evidenced by the few positive foci per nucleus ( Fig. 3 f) .
In contrast, there was divergent multi-nucleation and aberrant nuclei in end-stage porcine SMC which was significantly elevated in CCE-SMC ( Fig. 3 g, h) . There was a trend towards a greater number of H2AX-positive nuclei in CCE-SMC, and these exhibited a higher degree of DNA damage with multiple foci ( Fig. 3 i) .
Association of Experiments with Age
SMC were isolated from surgical samples acquired from a total of 31 patients undergoing AAA open repair (mean age 72.6 ± 1.1 years, range 67-87; 93% male) and from the SV from a total of 57 patients harvested sequentially during coronary artery bypass grafting (mean age 62.6 ± 1.5 years, range 40-83; 89% male; p < 0.001; Fig. 4 a) .
In order to determine whether chronological patient age accounted for the differences we observed, we performed a correlative analysis for chronological age in both the AAA and the SV groups. Here, the analysis was performed specifically on the subset of patient cells that were used for each particular experiment. Cells were selected for experimental use chronologically and not preselected according to clinical or cell behavioural data. This investigation revealed that patient donor age was not significantly correlated to SIRT-1 or miR-145 expression ( Fig. 4 b, c) , the number or morphology of nuclei ( Fig. 4 d,  e) , or the degree of γH2AX positivity ( Fig. 4 f) . We propose that these features are therefore markers of pathological, vascular aging rather than attributable to the age of the patient donor.
Discussion
AAA disease is a significant healthcare problem with high mortality from rupture. The present study builds on our previous work demonstrating that end-stage AAA-SMC and porcine CCE-SMC are significantly larger than non-aneurysmal controls [9] and it has revealed for the . Sub-confluent cells were cultured in full growth medium and imaged at ×100 magnification. a Abdominal aortic aneurysm (AAA)-SMC commonly exhibited granulation in the perinuclear region and often had a cytoskeleton that was visible under phase (arrows). Saphenous vein (SV)-SMC and internal mammary artery (IMA)-SMC did not exhibit these features. Representative images, with the previously described difference in cell size clearly evident [9] . Scale bar, 100 μm. b Cells were fixed and stained with rhodamine phalloidin to visualise the F-actin cytoskeleton (red). Nuclei were stained blue with DAPI. Truncated and disorganised F-actin filaments were apparent under both low (×200) and high (×630) magnification, whereas SV-SMC fibres were elongated and traversed the cells. Top: scale bar, 100 μm. Bottom: scale bar, 20 μm. c , d The same analyses were performed on control vehicle gel (VEH)-SMC and collagenase and elastase (CCE)-SMC from porcine carotid arteries maintained for 3 days in the bioreactor ("early stage"). Granulation and aberrant cytoskeletal features were very infrequent under any conditions. e , f Conversely, perinuclear granulation and truncation of the F-actin cytoskeleton were readily visible in CCE-SMC from 12-day bioreactor experiments ("end stage") compared to VEH-SMC. first time that SMC derived from both human end-stage AAA tissue and ex vivo protease-treated porcine arteries maintained under flow exhibit features consistent with premature aging and increased DNA damage. This could conceivably underlie, at least in part, their impaired functionality.
The morphological characteristics of aneurysmal SMC (both human and end-stage CCE) were distinct, compris- ing a large spread cell area and rhomboid morphology [9] . Importantly, an aberrant morphology was apparent in cells emerging early from primary explants (data not shown). All experiments in this study and in our previous report [9] were performed on early-passage cells (passages 3-6), an interval over which we have confirmed that morphological characteristics are retained [21] . In the current study, we have extended our morphological characterisation by noting marked aberrations in the F-actin cytoskeleton. Similar F-actin features -i.e., truncated and disorganised fibres -have also been described in SV-SMC from patients with type 2 diabetes (T2DM) [20] [21] [22] . As both aneurysm disease and T2DM are considered to be conditions characterised by premature aging [23, 24] , it is feasible that disorganisation of F-actin in SMC is a feature of aged cells rather than representative of a particular disease pathology per se. SMC are highly plastic and can switch between differentiated, contractile and dedifferentiated, synthetic phenotypes, which is essential to their function [5] . The synthetic phenotype is characterised by morphological changes including adoption of a rhomboid appearance, myofilament loss, and an increase in synthetic organelles including the Golgi apparatus and rough endoplasmic reticulum [5] . Whilst we did not investigate markers of secretory organelles, it is likely that the perinuclear granulation we observed in the human and end-stage porcine aneurysmal cells, in combination with an aberrant cell morphology and disorganisation of the cytoskeleton, are indicative of a switch towards a secretory phenotype. It has been suggested that this could be an artefact caused by the in vitro nature of this study and could have been induced due to the differences in cell size or proliferative capacity that we have previously described [9] . AAA-SMC are undeniably larger than SV-SMC in culture and they have a slower proliferative rate [9] ; however, their size and impaired proliferative capacity are comparable with our documented phenotypic characterisation of IMA-SMC [21] . In the present study, a substantially higher proportion of AAA-SMC exhibited "secretory" features compared to IMA-SMC ( Fig. 1 a, b) , asserting that our observations are not due to in vitro conditions but instead are related to their previous in vivo environment.
Cells that permanently withdraw from the cell cycle adopt a senescence-associated secretory phenotype characterised by secretion of various mediators, typically IL-1, IL-6, IL-8, and monocyte chemoattractant protein-1 [16] . These secreted factors can induce senescence in neighbouring cells via paracrine/autocrine mechanisms, a phenomenon known as a "bystander effect" [25] . AAA-SMC exhibit telomere attrition [26] and we previously demonstrated that aneurysmal SMC exhibit a greater degree of senescence, indicated by β-galactosidase staining [9] . We therefore examined the expression of sirtuins, longevity proteins whose expression is inversely correlated with cell age [27] . Indeed SIRT-1, via a p53-dependent mechanism, can promote DNA repair and regulate the cell cycle, thereby promoting viability and longevity [28] . Whilst lower expression levels of SIRT-1 in AAA-SMC compared to non-aneurysmal SV-SMC supports our hypothesis of premature aging, this was not a feature replicated in the porcine model (either early or end-stage) or in IMA-SMC, suggesting that SIRT-1 expression may be inherently variable between vascular beds. However, basal expression levels of SIRT-1 in porcine SMC were 2.6-to 4.9-fold higher than corresponding expression levels in human SMC, supporting the concept that the porcine cells were physiologically "younger" than the end-stage human cells. In patients with AAA, dilation progresses over many years [29] . In order to induce a temporally aged porcine model that more accurately mirrors the human condition, it seems likely that culture in the bioreactor over an extended period is necessary, whilst providing conditions that are able to maintain vessel viability throughout.
MiR-145 is highly expressed in SMC and it is involved in differentiation [24] and is reportedly dysregulated in a number of cardiovascular pathologies [21, 25] . MiR-145 is an important regulator of the vascular SMC phenotype, and we demonstrated its role in driving phenotypic Fig. 2 . Expression of markers related to DNA damage and senescence. Smooth muscle cells (SMC) were cultured for 4 days in full growth media and RNA isolated. a Expression of SIRT-1, SIRT-3, and SIRT-6, all of which are known to decline in senescent cells ( n = 10, * p < 0.05; ns, non-significant vs. saphenous vein [SV]-SMC). b ) Expression of miR-145, a microRNA involved in DNA damage and that we have previously shown to be up-regulated in senescent SMC from patients with type 2 diabetes [20] ( n = 12, * * * p < 0.001 vs. SV-SMC or internal mammary artery [IMA]-SMC). c , d In "early" or "end-stage" experiments, there was no difference in SIRT-1 or SIRT-3 expression amongst any conditions. SIRT-6 was not detected in porcine cells ( n = 3). e , f The expression of miR-145 was not affected by collagenase and elastase (CCE) in either "early" or "end-stage" experiments ( n = 3), in contrast to the increase seen in abdominal aortic aneurysm (AAA)-SMC. Identical experiments were performed on control and enzymetreated porcine SMC from "early-stage" experiments for multinucleation ( n = 3, ns = non-significant vs. VEH-SMC) ( d ), nuclear morphology ( n = 3, ns = non-significant vs. VEH-SMC) ( e ), andγH2AX-positive nuclei ( n = 3, ns = non-significant vs. VEH-SMC) ( f ). g-i Identical experiments were performed on control and enzyme-treated porcine SMC from "end-stage" experiments for multi-nucleation ( n = 3, * * p < 0.01 vs. VEH-SMC) ( g ), nuclear morphology ( n = 3, * p < 0.05 vs. VEH-SMC) ( h ), and γH2AX-positive nuclei ( n = 3, ns = non-significant vs. VEH-SMC) ( i ).
change in human SV-SMC. Specifically, over-expression of miR-145 caused cells to become large and spread, disrupted the F-actin cytoskeleton, and reduced proliferation. This previous report also discovered elevated levels of miR-145 in native T2DM-SMC compared to non-diabetic SV, which was maintained throughout serial passaging [20] . Importantly, this elevation was observed in agematched patients which strengthens the notion that miR-145 is unlikely to be related to donor age. Our data presented here and previously [9] indicate that an enlarged, slowly proliferating cell phenotype is common to both AAA-SMC and T2DM-SMC. Here we observed elevated levels (2.2-fold) of miR-145 relative to venous and arterial non-aneurysmal SMC. Interestingly, the expression of miR-145 is reportedly elevated in ascending aortic aneurysm tissue [30] . Increasing age is a key risk factor for the development of AAA, which is most prevalent in males over the age of 65 years [1] , and premature vascular aging is also considered to underlie the development of cardiovascular complications in T2DM [31] . SV-SMC from T2DM patients express miR-145 at levels comparable to those described here in AAA-SMC [20] ; it is therefore conceivable that miR-145 serves as a marker of prematurely aged vascular SMC in general, and it is not necessarily specific to a particular pathology. In the bioreactor, where the time course of vessel dilatation is accelerated, it is unlikely that porcine cells undergo a comparable sequential disease process following the application of CCE. A key driver of cellular aging is DNA damage, whereby cells temporarily withdraw from the cell cycle and undergo DNA repair to prevent mutations in future generations. When DNA damage is overwhelming to a degree that exceeds the capacity of the cell to undergo DNA repair, permanent withdrawal from the cell cycle and senescence or apoptosis ensues [32] . Multi-nucleation and nuclear deformation are features of sustained DNA damage and aging [13, 27] and, further, phosphorylation of histone H2AX (γH2AX) is an early event in double-stranded DNA damage signalling [28] . Our current and previous data demonstrate conclusively that aneurysmal SMC are senescent [9] ; therefore, it was logical to explore any evidence of persistent DNA damage. We examined multinucleation (a feature of senescent and damaged cells [33, 34] ), deformation of normal ovoid nuclear morphology (more common in aged and DNA damaged cells [35, 13] ), and the presence of γH2AX (an early event in doublestranded DNA damage [36] ). Our results show unequivocally that human AAA-SMC exhibit a greater extent of DNA damage than non-aneurysmal SMC, in agreement with a previous study that also examined γH2AX and 8-dihydro-8-oxo-2 ′ -deoxyguanosine as a marker of oxidative DNA damage [26] . However, in that study AAA-SMC were explored in situ in tissue sections or isolated as primary cells by a cytospin method without culturing [26] . It is notable that in early-stage PCA-SMC the presence of multi-nucleation was high in both VEH-and CCE-SMC alike. This was paralleled by a higher proportion of γH2AX-positive cells in both groups; however, these cells exhibited few foci in each nucleus compared with either human or porcine end-stage aneurysmal cells ( Fig. 3 c, f, i) . It could be argued that the procedure of preparing and placing vessels in the bioreactor induces transient and reversible DNA damage, although this would require additional corroboration.
Persistence of DNA damage throughout culture and passaging is likely explained by the existence of epigenetic mechanisms. A number of microRNA are known to regulate proteins involved in the DNA damage response pathway, e.g., miR-421 (targets ATM), miR-24 (targets H2AX), and miR-125b (targets p53). Furthermore, activation of the DNA damage response up-regulates transcription and processing of a further subset of miR including miR-34, miR-145, and miR-215 [reviewed in 37 ] . In the present study we observed persistent DNA damage in porcine cells without elevated levels of miR-145; therefore, it is unlikely that miR-145 is a causative factor of the DNA damage we observe in both human and porcine aneurysmal SMC. MiR-24 reportedly inhibits SMC proliferation [38] and miR-34 is up-regulated in senescent SMC [39] ; these are worthy of investigation and may represent promising candidates for future research.
In summary, our data support the notion that endstage aneurysmal SMC (both human and porcine) exhibit characteristics consistent with DNA damage and senescence associated a secretory phenotype. These features are not present in early-stage porcine SMC, suggesting that they are imparted later in the temporal progression of aneurysm development. Identifying the critical time point where DNA damage can first be detected may provide opportunities to develop interventions which could prevent or even reverse this damage. In this respect, application of a further interim time point in the bioreactor could provide an opportunity for evaluating potential therapeutic agents, introduced early and evaluated for efficacy at later times. In the longer term, these data may lead to development of new pharmacological interventions for AAA in humans.
